Peritoneal Dialysis Market Size Will Achieve USD 5.73 Billion By 2027 growing at 5.6% CAGR - Exclusive Report by Emergen Research

Peritoneal dialysis (PD) is a type of renal replacement therapy that uses the peritoneal membrane in the abdomen as a natural filter to remove waste and excess fluids from the body. The peritoneal dialysis market has been growing rapidly due to increasing prevalence of end-stage renal disease (ESRD) and rising demand for home-based dialysis treatments. The Global Peritoneal Dialysis Market is forecasted to be worth USD 5.73 billion by 2027, according to a new report by Emergen Research.

One of the major drivers of the peritoneal dialysis market is the rising prevalence of ESRD. According to the National Kidney Foundation, over 37 million people in the United States have chronic kidney disease, and approximately 750,000 Americans have ESRD. In addition, the global prevalence of chronic kidney disease is estimated to be around 9.1%Another factor driving the peritoneal dialysis market is the increasing preference for home-based dialysis treatments. Compared to hemodialysis, which is typically performed in a clinical setting, PD can be performed at home, providing patients with greater flexibility and independence. This has become particularly important during the COVID-19 pandemic, as many patients have been hesitant to visit hospitals and clinics for their dialysis treatments.

Despite these drivers, there are also several restraints that could limit the growth of the peritoneal dialysis market. One of the main challenges is the high cost of PD equipment and supplies, which can make it difficult for some patients to afford the treatment. In addition, there is a lack of awareness and education about PD among both patients and healthcare providers, which could limit its adoption.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/161

However, there are also several growth factors that are expected to drive the peritoneal dialysis market in the coming years. One of the key trends is the development of innovative PD technologies, such as automated peritoneal dialysis (APD) systems and wearable PD devices. These advancements are expected to make PD more convenient and user-friendly, which could help to increase its adoption.

According to a report by the Emergen Research, approximately 11% of ESRD patients in the United States were receiving PD in 2018, up from 8% in 2010. However, there is still significant room for growth, particularly in developing countries where access to healthcare and dialysis treatments is limited. In addition, the growing trend towards personalized medicine and precision healthcare could also create new opportunities for the peritoneal dialysis market, as patients are increasingly seeking treatments that are tailored to their individual needs.

Major Companies and Competitive Landscape:

Key players in the market Baxter International, Nipro, B. Braun Melsungen, DaVita Healthcare Partners, Covidien, Dialysis Clinic, Fresenius Medical Care, Diversified Specialty Institute Holdings, Medical Components, Huaren Pharmaceutical, NephroPlus, Northwest Kidney Centers, Satellite Healthcare, NxStage Medical, Renal Services, Sandor, Sichuan Kelun Pharmaceutical, and U.S. Renal Care, among others.

The peritoneal dialysis market is highly competitive and fragmented, with several major players operating in the space. Some of the key companies in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medionics International Inc., and Terumo Corporation.

Baxter International Inc. is a global healthcare company that offers a range of products and services in the areas of renal care, medication delivery, and surgical care. The company's peritoneal dialysis products include its Homechoice and Homechoice Pro APD systems, as well as its Amia and Kaguya PD cycler systems.

Fresenius Medical Care AG & Co. KGaA is a leading provider of dialysis products and services, with a strong presence in both hemodialysis and peritoneal dialysis. The company's peritoneal dialysis portfolio includes its SleepSafe Harmony APD system, as well as its Liberty and Fresenius PD cycler systems.

Medionics International Inc. is a medical device company that specializes in the development of innovative technologies for peritoneal dialysis. The company's flagship product is its Encapsulator device, which is used to encapsulate peritoneal dialysis solutions.

Terumo Corporation is a global healthcare company that offers a range of products and services in the areas of cardiac and vascular surgery, blood management, and renal therapies. The company's peritoneal dialysis products include its CapDial and CapDial Lite APD systems, as well as its SafeLine PD cycler system.

Want to learn more about the global Peritoneal Dialysis Market ? Access the full report with just one click! https://www.emergenresearch.com/industry-report/peritoneal-dialysis-market

Peritoneal Dialysis Market Segmentation :

The global peritoneal dialysis market has been segmented by Emergen Research on the basis of product, type, end-user, and region. Based on product, the market is divided into peritoneal dialysis solution, device, peritoneal dialysis set, catheter, and others. The peritoneal dialysis solution segment is expected to account for a significant share of the market over the forecast period, owing to the increasing demand for these solutions for the treatment of end-stage renal disease.

On the basis of type, the market has been segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The APD segment is expected to witness significant growth during the forecast period, due to the advantages offered by this type of dialysis, such as better patient outcomes and reduced treatment time.

Based on end-user, the market has been segmented into home-based dialysis and dialysis center & hospital based dialysis. The home-based dialysis segment is expected to witness significant growth during the forecast period, due to the increasing preference for home-based dialysis among patients, as it offers greater flexibility and convenience.

Regionally, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to account for a significant share of the market over the forecast period, due to the increasing prevalence of chronic kidney disease in the region, along with the growing adoption of peritoneal dialysis as a treatment option. The Asia Pacific region is also expected to witness significant growth during the forecast period, due to the increasing healthcare expenditure in countries such as China, Japan, and South Korea, along with the rising prevalence of chronic kidney disease in the region.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/161

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.